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C
ancer patients with advanced and incurable disease are as much the responsibility of
oncologists as those whose disease is potentially curable.  This is the message that is
emanating loud and clear from The European Society of Medical Oncologists.  In Europe,
as in the United States, the major professional bodies have declared that oncologists must
take responsibility for and be skilled in the care of their patients who cannot be cured.
Furthermore, they have asserted that this responsibility extends beyond the point when anti-
cancer treatments may no longer be helpful. 
As declared in the editorial heralding the ESMO policy statements: "the division of cancer
care into an initial trial primary antitumor therapies followed by hospice or palliative care for
patients who have progressive disease is anachronistic".  Since the goals of medical oncol-
ogy extend beyond the reduction of tumor burden and the deferral of death to incorporate a
qualitative dimension, there is need for a continuum in patient care in which both primary
therapies and supportive and palliative interventions are tailored to the clinical circum-
stances of the patient." (1). 
The care of patients with advanced and incurable cancer occupies a major part of most
oncologists practice (2).  This comes as no surprise given that the cure rate for cancer
remains less than 50% and that cancer continues to account for over 25% of all adult deaths
(3).  ESMO recognizes that a great many patients will not be cured, and that for them the
issues regarding the quality of their remaining time is critical, irrespective of the duration of
survival. It has been almost five years since ESMO, at the suggestion of the then national
representative from Israel (Prof Raphael Catane), established a special working group to
address the relationship between medical oncology and supportive/palliative care.  No one
at the time would have anticipated the impact of this initiative. Since then, ESMO has clari-
fied and ratified definitions of supportive and palliative care (Table 1), defined the responsi-
bilities of the oncologist in the provision of palliative and supportive care (Table 2), outlined
training requirements for oncologists in relation to these aspect of patient care (Table 3),
and established minimal standards for cancer centers (Table 4) (1).
These policies are binding upon all individual members, associated organizations and bod-
ies, and affiliated centers.
Table 1. ESMO definitions
Table 2. ESMO policy regarding the role of the oncologist in the provision of supportive and pallia-
tive carePolicy statements are not enough. ESMO knew it had a problem in the actual delivery of pal-
liative care by many oncologists, and it wanted to know exactly what and how widespread
those problems were.  To this end, the organization surveyed its membership to evaluate
the attitudes and actual practices of ESMO affiliated oncologists.  This survey (2), the most
comprehensive of its kind, found that as a whole ESMO oncologists had very favorable and
appropriate attitudes with regards to their responsibilities in the provision of supportive and
palliative care. Overwhelmingly, they saw it as their responsibility and they expressed com-
mitment to continuity of care and to the provision of high quality end of life care in cooper-
ation with other health care professionals.  On the downside, however, the survey found 
that there was a substantial gap between expressed beliefs and actual practice. For exam-
ple, whereas, 88.4% of respondents agreed that medical oncologists should coordinate the
care of cancer patients at all stages of disease including end of life care, in actual practice
only 43% of respondents reported that they commonly coordinate the care of cancer
patients at all stages of disease including end of life care, less than 50% collaborate com-
monly with any supportive/palliative care clinician (including social workers), only 39%
commonly coordinate meetings with the family of dying patients, and only 11.8% com-
monly manage delirium (despite the high prevalence of this problem among patients with
far advanced cancer).  Interestingly, whereas 60.4% of respondents reported that they were
expert in the management of the physical and psychological symptoms of advanced can-
cer, only 37.0% said most oncologists they knew were expert in the management of the
physical and psychological symptoms of advanced cancer.
Importantly, the survey highlighted that these was a close relationship between negative
attitudes toward palliative care, lack of personal care delivery, lack of consultation with pal-
liative care colleagues from other disciplines, and  "catastrophic fear" of burnout from
involvement in end of life care. Those clinicians with the greatest fear did the least, had neg-
ative attitudes, and not only did they not provide care they did not refer or consult with
appropriate clinicians expert in end of life care.  ESMO hopes that its new education policy
will better prepare oncologists for these aspects of care.
ESMO recognizes that oncologists work in a clinical context; some in private clinics, but
most in hospitals and cancer centers. It is incumbent upon cancer clinics and hospitals to
provide the infrastructure and supports needed to ensure adequate supportive and palliative
care. All patients with advanced, potentially life threatening illness must have access to a
social worker to help evaluate emotional and social coping and to assist in coordinating
care. Many patients will need ambulatory or inpatient care for management of physical or
psychological symptoms and, some will need access to inpatient end-of-life care.  These
aspects of care will need interdisciplinary cooperation, which often incorporate palliative
care or hospice specialists.  Not all patients needing inpatient end of life care can or will be
care for in oncology departments, but it is incumbent upon the treating oncologist to ensure
that this aspect of care be carries out with sensitivity and expertise.  Dying patients must
not be abandoned or be allowed to "fall between the cracks of the system".  Consequently,
the third of its policy statements descries minimal standards for supportive and palliative
care to be provided by cancer centers (Table 4). This policy applies not only to major com-
prehensive cancer centers, but to private clinics and hospital bases services also.
The steps taken thus far are a beginning. ESMO recognizes that it is trying to change a cul-
ture of care. Making palliative care a normative part of oncology practice, no less than the
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Table 3. ESMO’s 9 core skills for supportive and palliative care training for medical oncologists Table 4. Minimal standards for the provision of supportive and palliative care by cancer centersESMO and supportive care
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administration of chemotherapy or antiemetic is going to take time, energy, initiative and
reinforcement. ESMO regards the incorporation of supportive and palliative care into routine
cancer care as an expression of "good clinical practice".  For oncologists, neglecting the
issue is not an option and, indeed, it verges on malpractice.
Along with the policy statements, ESMO has undertaken a series of educational and incen-
tive programs to further promote this important endeavor. Among the most prominent of the
initiatives is an incentive program to give special recognition to centers that meet an espe-
cially high standard in the integration of oncology and palliative medicine. Already more
than20 centers have applied for this recognition.
This is a new direction for ESMO but it is a direction that the organization views as critical
to the development of our specialty as both a humane and responsible initiative.
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